Join
Live feed
·
INSIDERFilingvia Quantisnow
VolitionRX Limited logo

President and CEO Reynolds Cameron John bought $9,885 worth of shares (15,000 units at $0.66), increasing direct ownership by 0.57% to 2,624,847 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VNRX· VolitionRX Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VNRX (VolitionRX Limited) and more on Quantisnow.